Selected research
Industry Growth & Trends
Global Recombinant Collagen Industry Growth and Trends Forecast to 2032
Market perspective
The global Recombinant Collagen market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Recombinant Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Recombinant Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Recombinant Collagen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Recombinant Collagen include Giant Biogene, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu JLand Biotech, Jiangsu Chuangjian Medical Technology, ProColl, Evonik, Creative BioMart and CollPlant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Recombinant Collagen market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Recombinant Collagen market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Collagen market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Collagen.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Collagen market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Recombinant Collagen Market by Company
Giant Biogene
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
ProColl
Evonik
Creative BioMart
CollPlant
Recombinant Collagen Segment by Type
Recombinant Type III Collagen
Recombinant Type I Collagen
Recombinant Type XVII Collagen
Recombinant Collagen Segment by Application
Biomedicine
Beauty and Skin Care
Other
Recombinant Collagen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Collagen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Collagen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Collagen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Collagen manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Recombinant Collagen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Recombinant Type III Collagen
- Recombinant Type I Collagen
- Recombinant Type XVII Collagen
Applications
- Biomedicine
- Beauty and Skin Care
- Other
Companies covered
- Giant Biogene
- Shanxi Jinbo Bio-Pharmaceutical
- Jiangsu JLand Biotech
- Jiangsu Chuangjian Medical Technology
- ProColl
- Evonik
- Creative BioMart
- CollPlant
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Recombinant Collagen Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Recombinant Collagen Sales Estimates and Forecasts (2021-2032)
- 1.3 Recombinant Collagen Market by Type
- 1.3.1 Recombinant Type III Collagen
- 1.3.2 Recombinant Type I Collagen
- 1.3.3 Recombinant Type XVII Collagen
- 1.4 Global Recombinant Collagen Market Size by Type
- 1.4.1 Global Recombinant Collagen Market Size Overview by Type (2021-2032)
- 1.4.2 Global Recombinant Collagen Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Recombinant Collagen Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Recombinant Collagen Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Recombinant Collagen Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Recombinant Collagen Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Recombinant Collagen Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Recombinant Collagen Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Recombinant Collagen Industry Trends
- 2.2 Recombinant Collagen Industry Drivers
- 2.3 Recombinant Collagen Industry Opportunities and Challenges
- 2.4 Recombinant Collagen Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Recombinant Collagen Revenue (2021-2026)
- 3.2 Global Top Players by Recombinant Collagen Sales (2021-2026)
- 3.3 Global Top Players by Recombinant Collagen Price (2021-2026)
- 3.4 Global Recombinant Collagen Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Recombinant Collagen Major Company Production Sites & Headquarters
- 3.6 Global Recombinant Collagen Company, Product Type & Application
- 3.7 Global Recombinant Collagen Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Recombinant Collagen Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Recombinant Collagen Players Market Share by Revenue in 2025
- 3.8.3 2025 Recombinant Collagen Tier 1, Tier 2, and Tier 3
4 Recombinant Collagen Regional Status and Outlook
- 4.1 Global Recombinant Collagen Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Recombinant Collagen Historic Market Size by Region
- 4.2.1 Global Recombinant Collagen Sales in Volume by Region (2021-2026)
- 4.2.2 Global Recombinant Collagen Sales in Value by Region (2021-2026)
- 4.2.3 Global Recombinant Collagen Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Recombinant Collagen Forecasted Market Size by Region
- 4.3.1 Global Recombinant Collagen Sales in Volume by Region (2027-2032)
- 4.3.2 Global Recombinant Collagen Sales in Value by Region (2027-2032)
- 4.3.3 Global Recombinant Collagen Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Collagen by Application
- 5.1 Recombinant Collagen Market by Application
- 5.1.1 Biomedicine
- 5.1.2 Beauty and Skin Care
- 5.1.3 Other
- 5.2 Global Recombinant Collagen Market Size by Application
- 5.2.1 Global Recombinant Collagen Market Size Overview by Application (2021-2032)
- 5.2.2 Global Recombinant Collagen Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Recombinant Collagen Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Recombinant Collagen Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Recombinant Collagen Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Recombinant Collagen Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Recombinant Collagen Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Recombinant Collagen Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Giant Biogene
- 6.1.1 Giant Biogene Company Information
- 6.1.2 Giant Biogene Business Overview
- 6.1.3 Giant Biogene Recombinant Collagen Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Giant Biogene Recombinant Collagen Product Portfolio
- 6.1.5 Giant Biogene Recent Developments
- 6.2 Shanxi Jinbo Bio-Pharmaceutical
- 6.2.1 Shanxi Jinbo Bio-Pharmaceutical Company Information
- 6.2.2 Shanxi Jinbo Bio-Pharmaceutical Business Overview
- 6.2.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Collagen Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Collagen Product Portfolio
- 6.2.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments
- 6.3 Jiangsu JLand Biotech
- 6.3.1 Jiangsu JLand Biotech Company Information
- 6.3.2 Jiangsu JLand Biotech Business Overview
- 6.3.3 Jiangsu JLand Biotech Recombinant Collagen Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Jiangsu JLand Biotech Recombinant Collagen Product Portfolio
- 6.3.5 Jiangsu JLand Biotech Recent Developments
- 6.4 Jiangsu Chuangjian Medical Technology
- 6.4.1 Jiangsu Chuangjian Medical Technology Company Information
- 6.4.2 Jiangsu Chuangjian Medical Technology Business Overview
- 6.4.3 Jiangsu Chuangjian Medical Technology Recombinant Collagen Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Jiangsu Chuangjian Medical Technology Recombinant Collagen Product Portfolio
- 6.4.5 Jiangsu Chuangjian Medical Technology Recent Developments
- 6.5 ProColl
- 6.5.1 ProColl Company Information
- 6.5.2 ProColl Business Overview
- 6.5.3 ProColl Recombinant Collagen Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 ProColl Recombinant Collagen Product Portfolio
- 6.5.5 ProColl Recent Developments
- 6.6 Evonik
- 6.6.1 Evonik Company Information
- 6.6.2 Evonik Business Overview
- 6.6.3 Evonik Recombinant Collagen Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Evonik Recombinant Collagen Product Portfolio
- 6.6.5 Evonik Recent Developments
- 6.7 Creative BioMart
- 6.7.1 Creative BioMart Company Information
- 6.7.2 Creative BioMart Business Overview
- 6.7.3 Creative BioMart Recombinant Collagen Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Creative BioMart Recombinant Collagen Product Portfolio
- 6.7.5 Creative BioMart Recent Developments
- 6.8 CollPlant
- 6.8.1 CollPlant Company Information
- 6.8.2 CollPlant Business Overview
- 6.8.3 CollPlant Recombinant Collagen Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 CollPlant Recombinant Collagen Product Portfolio
- 6.8.5 CollPlant Recent Developments
7 North America by Country
- 7.1 North America Recombinant Collagen Sales by Country
- 7.1.1 North America Recombinant Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Recombinant Collagen Sales by Country (2021-2026)
- 7.1.3 North America Recombinant Collagen Sales Forecast by Country (2027-2032)
- 7.2 North America Recombinant Collagen Market Size by Country
- 7.2.1 North America Recombinant Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Recombinant Collagen Market Size by Country (2021-2026)
- 7.2.3 North America Recombinant Collagen Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Recombinant Collagen Sales by Country
- 8.1.1 Europe Recombinant Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Recombinant Collagen Sales by Country (2021-2026)
- 8.1.3 Europe Recombinant Collagen Sales Forecast by Country (2027-2032)
- 8.2 Europe Recombinant Collagen Market Size by Country
- 8.2.1 Europe Recombinant Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Recombinant Collagen Market Size by Country (2021-2026)
- 8.2.3 Europe Recombinant Collagen Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Recombinant Collagen Sales by Country
- 9.1.1 Asia-Pacific Recombinant Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Recombinant Collagen Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Recombinant Collagen Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Recombinant Collagen Market Size by Country
- 9.2.1 Asia-Pacific Recombinant Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Recombinant Collagen Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Recombinant Collagen Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Recombinant Collagen Sales by Country
- 10.1.1 South America Recombinant Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Recombinant Collagen Sales by Country (2021-2026)
- 10.1.3 South America Recombinant Collagen Sales Forecast by Country (2027-2032)
- 10.2 South America Recombinant Collagen Market Size by Country
- 10.2.1 South America Recombinant Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Recombinant Collagen Market Size by Country (2021-2026)
- 10.2.3 South America Recombinant Collagen Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Recombinant Collagen Sales by Country
- 11.1.1 Middle East and Africa Recombinant Collagen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Recombinant Collagen Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Recombinant Collagen Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Recombinant Collagen Market Size by Country
- 11.2.1 Middle East and Africa Recombinant Collagen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Recombinant Collagen Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Recombinant Collagen Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Recombinant Collagen Value Chain Analysis
- 12.1.1 Recombinant Collagen Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Recombinant Collagen Production Mode & Process
- 12.2 Recombinant Collagen Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Recombinant Collagen Distributors
- 12.2.3 Recombinant Collagen Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst